Cardiac autonomic dysfunction in adult congenital heart disease

Carmen Pizarro1, Franziska Luise Bosse2, Charlotte Begrich2

  • 1University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany. carmen.pizarro@ukbonn.de.

PubMed

Insights

Adults with congenital heart disease (ACHD) show impaired heart rate variability (HRV), which predicts mortality and sudden cardiac death (SCD). These HRV alterations are crucial for risk stratification in ACHD patients.

Area of Science:

  • Cardiology
  • Medical Science
  • Clinical Research

Background:

  • Advances in diagnosis and treatment have increased the adult population with congenital heart disease (ACHD).
  • Rhythm disorders remain a significant challenge in managing ACHD patients.
  • Heart rate variability (HRV) is a key indicator of autonomic nervous system function and cardiac health.

Purpose of the Study:

  • To investigate alterations in heart rate variability (HRV) in adults with congenital heart disease (ACHD).
  • To determine the prognostic value of HRV in predicting outcomes such as mortality and sudden cardiac death (SCD) in ACHD patients.

Main Methods:

  • Ninety-seven ACHD patients and 19 controls underwent 24-hour Holter monitoring.
  • Analysis included assessment of premature ventricular contractions and various HRV indices (time and frequency domains).
  • Patients were followed for a mean of 3.9 years to track mortality and SCD events.

Main Results:

  • ACHD patients exhibited a higher burden of premature ventricular contractions and significantly decreased HRV indices compared to controls.
  • NT-proBNP levels showed significant correlations with multiple time and frequency domain HRV parameters.
  • Reduced HRV parameters were associated with increased risk of mortality and survived SCD in ACHD patients.

Conclusions:

  • Adult congenital heart disease (ACHD) is associated with significant impairments in heart rate variability (HRV).
  • These HRV alterations have important prognostic implications for ACHD mortality and the risk of sudden cardiac death (SCD).
  • HRV assessment can aid in risk stratification and management of ACHD patients.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
14
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14